Gilead Sciences (NASDAQ:GILD – Get Free Report) and Ambrx Biopharma (NYSE:AMAM – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends. Earnings and Valuation This table compares Gilead Sciences […]
Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) saw a significant increase in short interest in January. As of January 15th, there was short interest totalling 453,600 shares, an increase of 125.7% from the December 31st total of 201,000 shares. Based on an average trading volume of 627,400 shares, the short-interest ratio is presently 0.7 […]
Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 453,600 shares, a growth of 125.7% from the December 31st total of 201,000 shares. Based on an average trading volume of 627,400 shares, the short-interest ratio […]
Assembly Biosciences, Inc. (NASDAQ:ASMB) Major Shareholder Alexander Schornstein Buys 299,994 Shares themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) major shareholder Alexander Schornstein acquired 299,994 shares of the stock in a transaction that occurred on Wednesday, January 17th. The stock was acquired at an average cost of $0.78 per share, for a total transaction of $233,995.32. Following the completion of the transaction, the insider now directly […]